Xenon Pharmaceuticals Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $964.8M
Liabilities Breakdown FY2023
Total Liabilities: $36.9M
Asset Breakdown
Total Assets: $964.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $148.6M | 15.4% |
| Accounts Receivable | $874.0K | 0.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $9.7M | 1.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $805.6M | 83.5% |
Liabilities Breakdown
Total Liabilities: $36.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.6M | 23.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $28.3M | 76.7% |